MARAVAI LIFESCIENCES HLDGS I's ticker is MRVI and the CUSIP is 56600D107. A total of 230 filers reported holding MARAVAI LIFESCIENCES HLDGS I in Q3 2021. The put-call ratio across all filers is 1.11 and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2024 | $144,274,036 | -23.2% | 20,150,005 | -7.1% | 12.02% | -24.7% |
Q1 2024 | $187,974,556 | +32.4% | 21,681,033 | 0.0% | 15.96% | +85.2% |
Q4 2023 | $142,010,766 | -34.5% | 21,681,033 | 0.0% | 8.62% | -34.5% |
Q3 2023 | $216,810,330 | -19.5% | 21,681,033 | 0.0% | 13.15% | +4.1% |
Q2 2023 | $269,495,240 | -11.3% | 21,681,033 | 0.0% | 12.63% | -15.9% |
Q1 2023 | $303,751,272 | -2.1% | 21,681,033 | 0.0% | 15.02% | -16.7% |
Q4 2022 | $310,255,582 | -43.9% | 21,681,033 | 0.0% | 18.04% | -44.8% |
Q3 2022 | $553,517,000 | -10.1% | 21,681,033 | 0.0% | 32.68% | +48.7% |
Q2 2022 | $615,958,000 | -19.4% | 21,681,033 | 0.0% | 21.97% | -9.3% |
Q1 2022 | $764,690,000 | -15.8% | 21,681,033 | 0.0% | 24.22% | -12.5% |
Q4 2021 | $908,435,000 | -14.6% | 21,681,033 | 0.0% | 27.70% | +2.6% |
Q3 2021 | $1,064,105,000 | +3.6% | 21,681,033 | -11.9% | 26.99% | -5.7% |
Q2 2021 | $1,027,079,000 | +4.2% | 24,612,474 | -11.0% | 28.61% | +2.9% |
Q1 2021 | $985,322,000 | +27.1% | 27,646,515 | 0.0% | 27.81% | +43.6% |
Q4 2020 | $775,485,000 | – | 27,646,515 | – | 19.37% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
GTCR LLC | 21,681,033 | $1,064,105,000 | 26.99% |
Ghisallo Capital Management LLC | 1,250,000 | $61,350,000 | 2.33% |
Beck Bode, LLC | 160,064 | $7,856,000 | 2.19% |
Select Equity Group, L.P. | 12,122,011 | $594,948,300,000 | 2.00% |
Pinz Capital Management, LP | 83,603 | $4,103,000 | 1.86% |
Monashee Investment Management LLC | 185,000 | $9,080,000 | 1.68% |
Ownership Capital B.V. | 2,717,559 | $133,378,000 | 1.51% |
Eversept Partners, LP | 327,810 | $16,088,915 | 1.12% |
Parkman Healthcare Partners LLC | 90,000 | $4,417,000 | 1.12% |
Connacht Asset Management LP | 28,569 | $1,402,000 | 0.91% |